Company Revenue

The company grew in the mid-teens for 2023 but can't fully go on offense until it resolves its supply chain...

The company's orthopedic sales grew nearly 10% in 2023, driven by strong procedure demand, leadership in robotics and momentum in...

The company grew in the mid-single-digits in 2023 as new products and recovering markets fueled its rebound to pre-COVID levels....

The company grew in the mid-teens in 3Q23 and sees competitors putting less focus on treating pediatric trauma and deformity....

The company notched its fifth consecutive quarter with more than 20% growth and is on track for arthroscopic MACI delivery...

The company grew 61% as-reported in the third quarter of 2023, or 1.2% on a pro forma basis including prior...

The company grew in the mid-teens during the third quarter of 2022, driven by sales force and active surgeon base...

The company grew more than 23% in 3Q23 but ultimately reduced its guidance because of higher-than-expected seasonality during the summer....

The company grew in the low single digits in the third quarter of 2023 as its OA pain sales volume...

The company's orthopedic sales grew in the mid-teens during the third quarter of 2023, as it continues to win market...